479 results
-
List item
Opinion/decision on a Paediatric investigation plan (PIP): purified diphtheria toxoid, Purified Tetanus Toxoid, Five component acellular pertussis [Purified Pertussis Toxoid (PT), Purified Filamentous Haemagglutinin (FHA), Purified Fimbriae Types 2 and 3 (FIM), and Purified Pertactin (PRN)], Inactivated poliomyelitis vaccine (Vero) – Type 1 (Mahoney), Type 2 (MEF-1) and Type 3 (Saukett), Purified polyribosylribitol phosphate capsular polysaccharide of Haemophilus influenzae type b covalently bound to Tetanus protein (PRP-T)
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Vaccines
PIP number: EMEA-000278-PIP01-08-M01, Route(s) of administration: Intramuscular use, Pharmaceutical form(s): Suspension for injection in pre-filled syringe, Suspension for injection in a vial
Decision date: 31/03/2009, Last updated: 18/05/2009, Compliance check: V, 18/09/2009polyribosylribitol phosphate capsular polysaccharide of Haemophilus … polyribosylribitol phosphate capsular polysaccharide of Haemophilus … polyribosylribitol phosphate capsular polysaccharide of Haemophilus … -
List item
National expert: Norbert Moller, Federal Office Of Consumer Protection And Food Safety (updated)
- Declaration of interests - 39.33 KB | PDF
- Curriculum Vitae - 21.6 KB | PDF
Norbert Moller … Norbert Moller … Vitae Personal information Norbert Moller Work experience … -
List item
National expert: Marion Moller, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 23.77 KB | PDF
Marion Moller … Marion Moller … Vitae Personal information Marion Moller Work experience … -
List item
National expert: Wim Van Molle, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 39.73 KB | PDF
- Curriculum Vitae - 41.84 KB | PDF
Wim Van Molle … Wim Van Molle … Vitae Personal information Wim Van Molle Work experience … -
List item
Human medicine European public assessment report (EPAR): Nimenrix
Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Meningitis, Meningococcal
Date of authorisation: 20/04/2012, Revision: 36, Authorised, Last updated: 17/07/2023contains small amounts of capsular polysaccharides (sugars from … -
List item
Human medicine European public assessment report (EPAR): Dasatinib Accord
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 24/03/2022,
, Revision: 1, Withdrawn, Last updated: 30/03/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Dasatinib Accordpharma
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 24/03/2022,, Revision: 1, Withdrawn, Last updated: 30/03/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Caspofungin Accord
caspofungin acetate, Candidiasis; Aspergillosis
Date of authorisation: 11/02/2016,, Revision: 6, Withdrawn, Last updated: 20/08/2021
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Degarelix Accord (updated)
degarelix acetate, Prostatic Neoplasms
Date of authorisation: 29/09/2023,, Authorised, Last updated: 08/11/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Zubsolv
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate, Opioid-Related Disorders
Date of authorisation: 10/11/2017, Revision: 10, Authorised, Last updated: 10/10/2023Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Pelgraz
pegfilgrastim, Neutropenia
Date of authorisation: 21/09/2018,
, Revision: 11, Authorised, Last updated: 15/09/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Tolvaptan Accord
Tolvaptan, Inappropriate ADH Syndrome, Authorised, Last updated: 14/08/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Voriconazole Accord
voriconazole, Aspergillosis; Candidiasis; Mycoses
Date of authorisation: 16/05/2013,, Revision: 17, Authorised, Last updated: 14/06/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Zolsketil pegylated liposomal
doxorubicin hydrochloride, liposomal, Ovarian Neoplasms; Sarcoma, Kaposi; Multiple Myeloma
Date of authorisation: 31/05/2022, Revision: 2, Authorised, Last updated: 05/09/2023Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Dabigatran Etexilate Accord
Dabigatran etexilate mesilate, Venous Thromboembolism; Arthroplasty, Replacement
Date of authorisation: 26/05/2023,, Authorised, Last updated: 31/05/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Camcevi
leuprorelin mesilate, Prostatic Neoplasms
Date of authorisation: 24/05/2022, Revision: 1, Authorised, Last updated: 12/05/2023Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Sorafenib Accord
Sorafenib tosilate, Carcinoma, Hepatocellular; Carcinoma, Renal Cell
Date of authorisation: 09/11/2022,, Authorised, Last updated: 25/11/2022
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Referral: Cyklo-f
tranexamic acid, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/05/2000, EC decision date: 12/09/2000, Last updated: 27/07/2000Cyklo-f is supplied as white, capsular film coated tablets containing … 1999. Cyklo-f is supplied as white, capsular film coated tablets containing … -
List item
Human medicine European public assessment report (EPAR): Zoledronic Acid Accord
zoledronic acid monohydrate, Hypercalcemia; Fractures, Bone; Cancer
Date of authorisation: 16/01/2014,, Revision: 9, Authorised, Last updated: 24/01/2022
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Repaglinide Accord
repaglinide, Diabetes Mellitus, Type 2
Date of authorisation: 22/12/2011,, Revision: 7, Authorised, Last updated: 21/01/2022
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Accord
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016,, Revision: 10, Authorised, Last updated: 27/10/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Abiraterone Accord
abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 26/04/2021,, Revision: 1, Authorised, Last updated: 25/09/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, Revision: 11, Authorised, Last updated: 22/09/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Deferasirox Accord
deferasirox, Iron Overload; beta-Thalassemia
Date of authorisation: 09/01/2020,, Revision: 5, Authorised, Last updated: 14/09/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona … -
List item
Human medicine European public assessment report (EPAR): Fingolimod Accord
fingolimod hydrochloride , Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 25/06/2020,, Revision: 4, Authorised, Last updated: 18/08/2023
Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona …